Ad
CLDX Short Information Celldex Therapeutics Inc.
home / stock / cldx / cldx short
Short Information | Celldex Therapeutics Inc. (NASDAQ:CLDX)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 3,208,536 |
| Total Actual Volume | 20,516,658 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 160,427 |
| Average Short Percentage | 17.98% |
Is there a CLDX Short Squeeze or Breakout about to happen?
See the CLDX Short Analysis for free Sign up or Login
Powered by Squeeze Report
CLDX Twenty Trading Day's Volume to Short Volume Chart
CLDX Twenty Trading Day Price Chart
CLDX Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 06-11-2025 | $21.05 | $20.42 | $21.32 | $20.4 | 904,280 | 204,954 | 22.66% |
| 06-10-2025 | $21.02 | $20.92 | $21.805 | $20.89 | 992,492 | 233,396 | 23.52% |
| 06-09-2025 | $21.83 | $20.71 | $21.83 | $20.055 | 851,207 | 146,612 | 17.22% |
| 06-06-2025 | $19.87 | $21.35 | $21.43 | $19.87 | 852,593 | 107,094 | 12.56% |
| 06-05-2025 | $19.56 | $19.53 | $19.765 | $19.245 | 667,715 | 71,926 | 10.77% |
| 06-04-2025 | $19.68 | $19.67 | $20.03 | $19.31 | 754,012 | 132,593 | 17.58% |
| 06-03-2025 | $19.92 | $19.87 | $20.56 | $19.47 | 2,485,387 | 238,064 | 9.58% |
| 06-02-2025 | $19.79 | $19.97 | $20.505 | $19.49 | 706,714 | 133,615 | 18.91% |
| 05-30-2025 | $19.62 | $19.78 | $19.86 | $18.8 | 923,822 | 118,725 | 12.85% |
| 05-29-2025 | $18.81 | $19.84 | $20.15 | $18.55 | 2,822,705 | 127,118 | 4.5% |
| 05-28-2025 | $19.8 | $18.66 | $20.23 | $18.66 | 1,027,797 | 125,042 | 12.17% |
| 05-27-2025 | $20.67 | $19.78 | $20.67 | $19.25 | 1,674,005 | 278,853 | 16.66% |
| 05-23-2025 | $19.86 | $20.35 | $20.51 | $19.85 | 477,438 | 108,644 | 22.76% |
| 05-22-2025 | $19.86 | $20.37 | $20.51 | $19.5 | 538,144 | 132,069 | 24.54% |
| 05-21-2025 | $20.03 | $19.95 | $20.86 | $19.39 | 1,329,891 | 245,560 | 18.46% |
| 05-20-2025 | $20.72 | $20.49 | $21.075 | $20.145 | 872,917 | 218,290 | 25.01% |
| 05-19-2025 | $20.29 | $20.91 | $21.13 | $19.93 | 614,384 | 157,164 | 25.58% |
| 05-16-2025 | $20.05 | $20.45 | $20.69 | $19.84 | 705,960 | 105,544 | 14.95% |
| 05-15-2025 | $19 | $20.1 | $20.15 | $18.78 | 615,545 | 161,154 | 26.18% |
| 05-14-2025 | $19.67 | $18.94 | $19.9 | $18.465 | 699,650 | 162,119 | 23.17% |
News, Short Squeeze, Breakout and More Instantly...
Celldex Therapeutics Inc. Company Name:
CLDX Stock Symbol:
NASDAQ Market:
-2.06% G/L:
$20 Last:
207,661 Volume:
$20.13 Open:
$20.42 Close:
Celldex Therapeutics Inc. Website:
Ad
-
HAMPTON, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that data from the Company’s Phase 2 study of barzolvolimab in chronic spontaneous urticaria will be presented at the EAACI Congress 2025 being held in Glasgow, Scotland. Abstracts will be available on t...
-
HAMPTON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that Denice M. Torres has been elected to the company’s Board of Directors. "We are excited to welcome Denice to the Celldex Board of Directors," said Anthony Marucci, Co-founder, ...
-
Strong execution and progress across pipeline with multiple key data read outs expected in 2025 Late breaking oral presentation on Phase 2 CSU program at EAACI 2025 in June Phase 3 barzolvolimab CSU studies enrollment ongoing; Phase 3 program in CIndU under development Pha...